The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells

Stem Cells

Volumn 33, Issue 4, 2015, Pages 1130-1141

  Ferrell, Patrick I ^a,b   Xi, Jiafei ^a,b   Ma, Chao ^a,b   Adlakha, Mitali ^a,b   Kaufman, Dan S ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Embryonic stem cells; Hematopoiesis; Hematopoietic progenitor cells; Induced pluripotent stem cells

Indexed keywords

ACTIVIN; CD34 ANTIGEN; CD45 ANTIGEN; NODAL SIGNALING PROTEIN; TRANSCRIPTION FACTOR RUNX1; RUNX1 PROTEIN, HUMAN;

ADHERENT CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; ENHANCER REGION; FETUS LIVER; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INVERTED TERMINAL REPEAT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLURIPOTENT STEM CELL; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TIME LAPSE IMAGING; UMBILICAL CORD BLOOD; BIOSYNTHESIS; GENETICS; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY;

CORE BINDING FACTOR ALPHA 2 SUBUNIT; EMBRYONIC STEM CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PROMOTER REGIONS, GENETIC;

EID: 84925636915     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1940     Document Type: Article

References (63)

1. Thomson JA., Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
2. Kaufman DS., Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood 2009; 114: 3513-3523.
3. Muller AM, Dzierzak EA., ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 1993; 118: 1343-1351.
4. Muller AM, Medvinsky A, Strouboulis J, et al. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994; 1: 291-301.
5. de Bruijn MF, Speck NA, Peeters MC, et al. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J 2000; 19: 2465-2474.
6. Noort WA, Wilpshaar J, Hertogh CD, et al. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant 2001; 28: 163-171.
7. Tian X, Woll PS, Morris JK, et al. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 2006; 24: 1370-1380.
8. Wang L, Menendez P, Shojaei F, et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 2005; 201: 1603-1614.
9. Ledran MH, Krassowska A, Armstrong L, et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 2008; 3: 85-98.
10. Amabile G, Welner RS, Nombela-Arrieta C, et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 2013; 121: 1255-1264.
11. Suzuki N, Yamazaki S, Yamaguchi T, et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 2013; 21: 1424-1431.
12. Okuda T, van Deursen J, Hiebert SW, et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330.
13. Wang Q, Stacy T, Binder M, et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996; 93: 3444-3449.
14. Cai Z, de Bruijn M, Ma X, et al. Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity 2000; 13: 423-431.
15. Chen MJ, Yokomizo T, Zeigler BM, et al. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009; 457: 887-891.
16. Dowdy CR, Xie R, Frederick D, et al. Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation. Hum Mol Genet 2010; 19: 1048-1057.
17. Fujita Y, Nishimura M, Taniwaki M, et al. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Biochem Biophys Res Commun 2001; 281: 1248-1255.
18. Bee T, Swiers G, Muroi S, et al. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis. Blood 2010; 115: 3042-3050.
19. Tsuzuki S, Seto M., Expansion of functionally defined mouse hematopoietic stem and progenitor cells by a short isoform of RUNX1/AML1. Blood 2012; 119: 727-735.
20. Challen GA, Goodell MA., Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells. Exp Hematol 2010; 38: 403-416.
21. Bee T, Liddiard K, Swiers G, et al. Alternative Runx1 promoter usage in mouse developmental hematopoiesis. Blood Cells Mol Dis 2009; 43: 35-42.
22. Sroczynska P, Lancrin C, Kouskoff V, et al. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis. Blood 2009; 114: 5279-5289.
23. Nottingham WT, Jarratt A, Burgess M, et al. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood 2007; 110: 4188-4197.
24. Ng CE, Yokomizo T, Yamashita N, et al. A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells. Stem Cells 2010; 28: 1869-1881.
25. Ran D, Shia WJ, Lo MC, et al. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood 2013; 121: 2882-2890.
26. Newman M, Lardelli M., A hyperactive sleeping beauty transposase enhances transgenesis in zebrafish embryos. BMC Res Notes 2010; 3: 282.
27. Ng ES, Davis R, Stanley EG, et al. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc 2008; 3: 768-776.
28. Wilber A, Linehan JL, Tian X, et al. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 2007; 25: 2919-2927.
29. Klimchenko O, Mori M, Distefano A, et al. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 2009; 114: 1506-1517.
30. Notta F, Doulatov S, Laurenti E, et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011; 333: 218-221.
31. Gori JL, Chandrasekaran D, Kowalski JP, et al. Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells. Blood 2012; 120: e35-e44.
32. Majeti R, Park CY, Weissman IL., Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 2007; 1: 635-645.
33. Kaufman DS, Hanson ET, Lewis RL, et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001; 98: 10716-10721.
34. Chadwick K, Wang L, Li L, et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003; 102: 906-915.
35. Vodyanik MA, Thomson JA, Slukvin II., Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006; 108: 2095-2105.
36. + progenitors. J Clin Investig 2009; 119: 2818-2829.
37. Kissa K, Herbomel P., Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010; 464: 112-115.
38. Boisset JC, van Cappellen W, Andrieu-Soler C, et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010; 464: 116-120.
39. Lam EY, Hall CJ, Crosier PS, et al. Live imaging of Runx1 expression in the dorsal aorta tracks the emergence of blood progenitors from endothelial cells. Blood 2010; 116: 909-914.
40. Nostro MC, Cheng X, Keller GM, et al. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2008; 2: 60-71.
41. Pearson S, Sroczynska P, Lacaud G, et al. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 2008; 135: 1525-1535.
42. Kennedy M, Awong G, Sturgeon CM, et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2012; 2: 1722-1735.
43. Knorr DA, Ni Z, Hermanson D, et al. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med 2013; 2: 274-283.
44. Gan OI, Murdoch B, Larochelle A, et al. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 1997; 90: 641-650.
45. Pflumio F, Izac B, Katz A, et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 1996; 88: 3731-3740.
46. Rollini P, Kaiser S, Faes-van't Hull E, et al. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood 2004; 103: 1166-1170.
47. Chen Y, Jacamo R, Konopleva M, et al. CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia. J Clin Investig 2013; 123: 2395-2407.
48. Cai WY, Wei TZ, Luo QC, et al. The Wnt-beta-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion. J Cell Sci 2013; 126: 2877-2889.
49. + bone marrow cells of patients with myelodysplastic syndromes. Leuk Res 2013; 37: 251-258.
50. Liu Y, Yin B, Zhang C, et al. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Biochem Biophys Res Commun 2012; 417: 371-375.
51. Shu J, Xia Z, Li L, et al. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biol 2012; 9: 1275-1287.
52. Li X, Li XQ, Zhang JH, et al. Differential expression profiles of MicroRNA during the development of human cord blood CD34(+) CD38(-) cells to CD34(+)CD38(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16: 589-592.
53. Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86.
54. Pereira LA, Wong MS, Mossman AK, et al. Pdgfralpha and Flk1 are direct target genes of Mixl1 in differentiating embryonic stem cells. Stem Cell Res 2012; 8: 165-179.
55. Hatzistavrou T, Micallef SJ, Ng, ES, et al. ErythRED, a hESC line enabling identification of erythroid cells. Nat Methods 2009; 6: 659-662.
56. North TE, de Bruijn MF, Stacy T, et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 2002; 16: 661-672.
57. Park TS, Zimmerlin L, Zambidis ET., Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells. Cytometry A 2013; 83: 114-126.
58. Kyba M, Perlingeiro RC, Daley GQ., HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002; 109: 29-37.
59. Chan KM, Bonde S, Klump H, et al. Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood 2008; 111: 2953-2961.
60. Guo H, Ma O, Speck NA, et al. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis. Blood 2012; 119: 4408-4418.
61. Friedman AD., Transcriptional control of granulocyte and monocyte development. Oncogene 2007; 26: 6816-6828.
62. Huang G, Zhang P, Hirai H, et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet 2008; 40: 51-60.
63. Zarnegar MA, Chen J, Rothenberg EV., Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements. Mol Cell Biol 2010; 30: 4922-4939.